NSC232003
Based on 5 publication(s) in Google Scholar
NSC232003 is a highly potent and cell-permeable UHRF1 inhibitor, which inhibits DNA methylation in vitro and disrupts DNMT1/UHRF1 interactions at a cellular level.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.94%
- CAS No.: 1905453-18-0
- Formule: C6H7N3O3
- Masse moléculaire:169.14
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
Oxygen Sensing Compound Library
HY-L045
-
Ubiquitination Compound Library
HY-L050
-
Anti-Liver Cancer Compound Library
HY-L101
-
Metabolic Enzyme Compound Library
HY-L146
-
Mitophagy Compound Library
HY-L180
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Amino Acid Metabolism Compound Library
HY-L189
-
Cell Proliferation Compound Library
HY-L201
-
High-Throughput Bioactive Compound Library
HY-L205
-
Metabolism/Protease Compound Library
HY-L012
-
Anti-Cancer Compound Library
HY-L025
Publications Citing Use of MedChemExpress (MCE) NSC232003
More
Customer Validation & Images
-
IF
-
Apoptosis Analysis
-
Cell Imaging/Staining
Activité biologique
UHRF1[1]
NSC232003, a uracil derivative freely available by the NCI/DTP repository, provides a versatile lead for developing highly potent and cell-permeable UHRF1 inhibitors that will enable dissection of DNA methylation inheritance. NSC232003 is indeed an effective DNA methylation inhibitor and indicate that this particular nucleotide scaffold could provide a versatile basis for the design of potent UHRF1 inhibitors. NSC232003 is predicted to be partially deprotonated at pH 7, as the pKa of the more acidic imide nitrogen of the pyrimidine ring is a value of 7.6 in NSC232003. The DNMT1/UHRF1 interactions are significantly reduced after 4 h of incubation of U251 glioma cells with the most potent compound NSC232003, showing a 50% interaction inhibition at 15 μM as well as induction of global DNA cytosine demethylation as measured by ELISA[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1905453-18-0
-
Appearance Solid
-
Masse moléculaire 169.14
-
Formule C6H7N3O3
-
Color White to off-white
-
SMILES
O=C1NC(/C(C=N1)=C(NO)/C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
EBioMedicine
2022 May;79:103985. PMID: 35429693 -
JCI Insight
Liposomal UHRF1 siRNA shows lung fibrosis treatment potential by regulating fibroblast activation. [Abstract]2022 Sep 27;e162831. PMID: 36166308 -
J Biol Chem
UHRF1-mediated ubiquitination of nonhomologous end joining factor XLF promotes DNA repair in human tumor cells. [Abstract]2024 Nov;300(11):107823. PMID: 39341501
NSC232003 purchased from MedChemExpress. Usage Cited in: J Biol Chem. 2024 Nov;300(11):107823. [Abstract]
HeLa WT cells were transfected with GFP-UHRF1, after 4 h of treatment with 20 μM NSC232003, dynamic recruitment of UHRF1 to DNA damage tracks were monitored using laser micro-irradiation–coupled live-cell imaging.
NSC232003 purchased from MedChemExpress. Usage Cited in: J Biol Chem. 2024 Nov;300(11):107823. [Abstract]
HeLa cells were irradiated with 5 Gy IR for 1 h, treated with 20 μM VP16 for 2 h, and then released for 2 h before being treated with 20 μM NSC232003 for 4 h. Apoptosis was assessed using the Annexin V-FITC apoptosis detection kit.
NSC232003 purchased from MedChemExpress. Usage Cited in: J Biol Chem. 2024 Nov;300(11):107823. [Abstract]
HeLa cells were irradiated with IR for 6 h and then reseeded in 6-well plates. Twenty micromolars of NSC232003 was added, and cell clones were analyzed for relative viability by crystal violet staining.
-
J Appl Toxicol
2025 Jun 12. PMID: 40509639 -
Cytoskeleton (Hoboken)
Analyses of Off-Target Effects on Cardiac and Skeletal Muscles by Berberine, a Drug Used to Treat Cancers and Induce Weight Loss. [Abstract]2025 Jun;82(6):344-359. PMID: 39526308
Solvant et solubilité
H2O : 2 mg/mL (11.82 mM; Need ultrasonic)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 4.76 mg/mL (28.14 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
Pureté et documentation
-
Fiche technique (273 KB)
-
SDS (604 KB)
- English - EN (604 KB)
- Français - FR (604 KB)
- Deutsch - DE (604 KB)
- Norwegian - NO (604 KB)
- Español - ES (604 KB)
- Swedish - SV (604 KB)
- Italian - IT (604 KB)
- Korean - KR (604 KB)
- Portuguese - PT (604 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 5.9123 mL | 29.5613 mL | 59.1226 mL | 147.8066 mL |
| 5 mM | 1.1825 mL | 5.9123 mL | 11.8245 mL | 29.5613 mL | |
| 10 mM | 0.5912 mL | 2.9561 mL | 5.9123 mL | 14.7807 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
NSC232003 Related Classifications
HY-103236 Related Classifications
Powered by Bioz